Skip to main content
main-content

Chronic kidney disease


Browse the latest news, expert commentary, and educational content on chronic kidney disease.


Highlights

15-09-2021 | ESC 2021 | Conference coverage | Video

FIGARO: Where will finerenone fit into diabetic kidney disease treatment?

David Wheeler talks about the findings of the FIGARO trial, the use of finerenone in people with type 2 diabetes, and how this may fit with SGLT2 inhibitors.

07-09-2021 | Nephropathy | Ask the expert | Article

DKD treatment update: SGLT2 inhibitors and finerenone

Nephrologist Ian de Boer joins primary care physician Amrit Lamba to discuss how the recent approval of finerenone and extension of the dapagliflozin label is likely to influence the treatment of kidney disease in people with type 2 diabetes.

28-07-2021 | Complications | News

Complications ‘accumulate rapidly’ in youth-onset type 2 diabetes

The risk for diabetes-related complications increases over time among people with youth-onset type 2 diabetes, with the majority having at least one microvascular complication by the time of young adulthood, suggest follow-up results from the TODAY study.

More on chronic kidney disease

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits